Status:
COMPLETED
Cognition and Magnetic Resonance Imaging of Brain Inflammation in Obesity
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Obesity
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The rate of obesity in the United States is high and is a risk factor for concurrent cognitive impairment and, in late life, dementias such as Alzheimer's disease. In order to prevent or reduce cognit...
Detailed Description
Initially, normal-weight or obese potential participants are screened by a phone interview that assesses medical history. Obtainment of informed consent and further screening occurs on the day of the ...
Eligibility Criteria
Inclusion
- Non-obese (body mass index = 18 - 25 kg/m\^2) or Obese (body mass index ≥ 30 kg/m\^2
- Any race or ethnicity
- Native English speaker
Exclusion
- Past or current diabetes
- Current psychotropic medication use
- Past or current neurological illness
- Past or current substance or alcohol misuse
- Past or current mental illness
- Current binge eating disorder
- Magnetic resonance imaging contraindications
- Pregnancy
- Currently lactating
- Tobacco use within past month
- Over 350 lb
Key Trial Info
Start Date :
March 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04116229
Start Date
March 19 2019
End Date
October 30 2020
Last Update
March 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110